Studies in different cancer models have shown that the presence of GAL-1 in the tumor microenvironment significantly contributes to tumor progression by suppressing the local immune response and thus promoting angiogenesis, tumor cell migration, and chemotherapy resistance [28]. Here, LGALS1 is linked to neoplasm.